Drugs and uses to modulate inflammation, metabolic disorders and other conditions
US2007275937A1
Therapeutic treatment methods
WO2004089304A2
Antiandrogens with marginal agonist activity and methods of use
WO2004019953A1
Therapeutic treatment methods
ZA200103845B
Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in treatment of toxoplasmosis and in the treatment of cryptosporidiosis.
ZA200103852B
Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of African and American Trypanosomiasis.
AU4177901A
Method of treatment of prostate cancer
WO0123405A2
Therapeutic treatment of androgen receptor driven conditions
WO0130802A2
Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
TW200519124A
Immune modulating compounds and pharmaceutical compositions thereof
US6667299B1
Pharmaceutical compositions and treatment methods
HU0203429A2
Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone, process for their preparation and pharmaceutical compositions containing them
CN1837231A
Immunomodulatory steroids, in particular the hemihydrate of 16, alpha-bromoepiandrosterone
EP1150665A2
Use of statins for treating viral infections
AU1579700A
Cytokine combination therapy
AU1923500A
Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in treatment of toxoplasmosis and in the treatment of cryptosporidiosis
BR9915623A
Use of 17-ketoesteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and in the treatment of African and American trypanosomiasis
NZ511721A
Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis C virus and other togaviruses
